Alcohol-related liver disease (ALD) has emerged as a pressing global health concern, with excessive alcohol consumption contributing to a spectrum of liver disorders, including fatty liver, hepatitis, cirrhosis, and liver cancer. Recent studies indicate a steady rise in alcohol-induced liver complications, driven by changing lifestyle patterns, urbanization, and social drinking trends. ALD not only poses a significant clinical burden but also exerts economic pressure on healthcare systems due to long-term management costs.